-
Mashup Score: 0
Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for treatment-naive patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) may include issues related to access, cost, and patient adherence, and highlight the need for ongoing research and collaboration to optimize BTKi use and improve patient outcomes in both diseases.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Duchenne gene therapy from Solid Biosciences produces promising results in early study - 4 day(s) ago
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise https://t.co/vVUMLjlP2j
-
-
Mashup Score: 16Mass. (un)vaccination: A new wave of vaccine skepticism threatens readiness for the next pandemic - The Boston Globe - 4 day(s) ago
Health care providers say that hesitation and outright resistance to vaccines have become disturbingly common even in Massachusetts, a state that was at the forefront of developing and distributing COVID shots.
Source: www.bostonglobe.comCategories: General Medicine News, General HCPsTweet-
RT @PeterHotez: Vaccine skepticism wave bodes poorly for next pandemic. My comments @BostonGlobe https://t.co/jsobyFEtv9
-
-
Mashup Score: 1Let your mind protect your heart - 4 day(s) ago
Stress is hard on your heart. But all you need is a few minutes a day to relax into healthier blood pressure and lower cardiac risk. Find out how.
Source: www.mayoclinic.orgCategories: General Medicine News, General HCPsTweet-
Feeling anxious? When you're stressed, your body responds by increasing #stress hormones and raising blood pressure. It's time to start relaxing. Here's how to cultivate a relaxed state of mind. https://t.co/Mwzvqg09gO https://t.co/BMVmWMDuR1
-
-
Mashup Score: 0The development of an innovative method to improve the dissolution performance of rivaroxaban - 4 day(s) ago
Recent advancements in the formulation of solid dosage forms involving active ingredient-cyclodextrin complexes have garnered considerable attention in pharmaceutical research. While previous studies predominantly focused on incorporating these complexes into solid states, issues regarding incomplete inclusion prompted the exploration of novel methods. In this study, we aimed to develop an innovative approach to integrate liquid-state drug-cyclodextrin inclusion complexes into solid dosage forms.
Source: www.cell.comCategories: General Medicine News, General HCPsTweet-
The development of an innovative method to improve the dissolution performance of rivaroxaban. Check out the full study from researchers at University of Medicine and Pharmacy "Carol Davila" Bucharest in @HeliyonJournal #bps2025 https://t.co/3xX4VTGQrT
-
-
Mashup Score: 1Duchenne gene therapy from Solid Biosciences produces promising results in early study - 4 day(s) ago
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Solid's Duchenne gene therapy shows early promise https://t.co/O3QFEKKZgn
-
-
Mashup Score: 0A Kid Made a Small Fortune Selling Off a Memecoin He’d Made on a Lark. Then Came the Backlash - 4 day(s) ago
ON THE EVENING of November 19, art adviser Adam Biesk was finishing work at his California home when he overheard a conversation between his wife and son. The son, in his early teens, was saying he had just made a ton of money on a cryptocurrency that he himself created.
Source: apple.newsCategories: General Medicine News, General HCPsTweet-
A Kid Made a Small Fortune Selling Off a Memecoin He’d Made on a Lark. Then Came the Backlash - WIRED https://t.co/MTwdz8CPcK
-
-
Mashup Score: 2
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, outside the U.S.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, outside the U.S. https://t.co/M3UcWQQxOp
-
-
Mashup Score: 1X - 4 day(s) ago
Who are the top followers of @EvanKirstel? Analyze Evan Kirstel’s
Source: x.comCategories: General Medicine News, General HCPsTweet-
https://t.co/jt7tNNZQD6
-
-
Mashup Score: 0EU joint defence debt has many hoops to go through - 4 day(s) ago
Europe’s leaders are caught between the need to boost their defence spending in a hurry, and their tight finances. The European leaders gathered by French President Emmanuel Macron on Monday at a rapidly convened summit in Paris may have debated the creation of a joint borrowing vehicle that would help shore up their militaries while mutualising the associated fiscal cost. It may take some time before the idea sees the light of day.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet-
From Breakingviews - EU joint defence debt has many hoops to go through https://t.co/eKIF1ngogF https://t.co/eKIF1ngogF
-
Learn about challenges in implementing emerging #BTKI regimens for treatment-naive patients with chronic lymphocytic leukemia and mantle cell lymphoma from Ryan Haumschild, PharmD, MS, MBA, CPEL, and Tara Graff, DO. Listen now: https://t.co/9uxcNNzAdN